I'm LongbridgeAI, I can summarize articles.Equifax beat Q2 earnings and revenue estimates but issued lower Q3 forecasts, causing shares to fall 2.5%. Consequently, analysts from Needham, Barclays, and RBC Capital lowered their price targets while maintaining their respective buy or hold ratings on the stock.
Equifax Inc. (NYSE:EFX) on Tuesday posted upbeat second-quarter results and issued third-quarter forecasts that came in below Wall Street expectations.
Adjusted earnings were $2.25 per share, topping the analyst consensus estimate of $2.20. Revenue rose 11% year over year to $1.70 billion, ahead of the $1.696 billion consensus estimate. On a local currency basis, revenue increased 10%.
Equifax narrowed its full-year adjusted EPS guidance to $8.39 to $8.69 from a previous range of $8.34 to $8.74. The midpoint remains in line with the analyst consensus estimate of $8.60.
The company also tightened its full-year revenue outlook to $6.71 billion-$6.78 billion from $6.685 billion-$6.805 billion. The midpoint is broadly in line with the consensus estimate of $6.764 billion.
For the third quarter, Equifax forecast adjusted EPS of $2.15 to $2.25, below the analyst estimate of $2.26. It expects revenue of $1.68 billion to $1.71 billion, compared with the consensus estimate of $1.711 billion.
Equifax shares fell 2.5% to trade at $168.72 on Wednesday.
These analysts made changes to their price targets on Equifax following earnings announcement.
- Needham analyst Kyle Peterson maintained the stock with a Buy and lowered the price target from $265 to $245.
- Barclays analyst Manav Patnaik maintained the stock with an Equal-Weight rating and cut the price target from $215 to $200.
- RBC Capital analyst Ashish Sabadra maintained the stock with an Outperform rating and lowered the price target from $222 to $194.
Considering buying EFX stock? Here’s what analysts think:
Photo via Shutterstock